<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Surface sialylation and glycosylation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells is known to affect various biological phenomena </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we analyzed the regulatory roles of cell surface sialylation in cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to galectin-1 in the human diffuse large B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) cell line, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2, and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-8 </plain></SENT>
<SENT sid="2" pm="."><plain>Vibrio cholerae neuraminidase treatment enhanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2 cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to galectin-1, suggesting that <z:chebi fb="0" ids="26667">sialic acid</z:chebi> inhibits <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2 cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to galectin-1 </plain></SENT>
<SENT sid="3" pm="."><plain>The data from employing two different neuraminidases, Vibrio cholerae and <z:e sem="disease" ids="C0027983" disease_type="Disease or Syndrome" abbrv="">Newcastle disease</z:e> virus neuraminidase, showed that alpha2,6-linked <z:chebi fb="0" ids="26667">sialic acid</z:chebi> plays an important role in the inhibition of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2 cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to galectin-1 </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, neuraminidase treatment enhanced the cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to galectin-1 much more with the highly sialylated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-8 3G3 clone than with the hyposialylated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-8 3D2 clone </plain></SENT>
<SENT sid="5" pm="."><plain>Flow cytometric analysis revealed the expression of partially sialylated L-PHA reactive <z:chebi fb="2" ids="50699">oligosaccharides</z:chebi> on the surfaces of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2 cells </plain></SENT>
<SENT sid="6" pm="."><plain>Swainsonine (SW) treatment also enhanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2 cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to galectin-1 </plain></SENT>
<SENT sid="7" pm="."><plain>These data indicate that SW treatment decreased sialylated L-PHA reactive <z:chebi fb="2" ids="50699">oligosaccharides</z:chebi> resulting in cell surface desialylation and leading to enhancement of cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to galectin-1 </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, alteration of cell surface sialylation or N-glycan expression regulates cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to galectin-1 in human malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>